Tsiklovir - antiviral
The active ingredient Tsiklovira - acyclovir, has antiviral activity.
The drugs are based on the formation of a "defective" virus DNA that results in suppression of virus reproduction of new generations.
Tsiklovir exhibits activity against cytomegalovirus and viruses:
• Varicella zoster;
• Herpes simplex (types 1 and 2);
• Epstein-Barr virus.
Tsiklovir produced in the form of tablets containing the active ingredient acyclovir at 200 mg, and in the form of creams and ointments for topical use and eye ointment.
The active substance acyclovir as part of some other drugs, such as Vivoraks, Provirsan, Medovir, Gerperaks, Atsigerpin and Acyclovir.
According to the instructions Tsiklovir prescribed for systemic use in the following cases:
• In the treatment of infections caused by Varicella zoster virus and Herpes simplex types 1 and 2, as well as a part of preventive measures, including the condition on the background of reduced immunity;
• In the complex treatment after bone marrow transplantation in patients with severe immunodeficiency;
• For the prevention of cytomegalovirus infection after surgery for a bone marrow transplant.
Tsiklovir eye ointment topically applied in ophthalmology for the treatment of keratitis, as well as other eye lesions which are caused by the virus Herpes simplex.
External ointment and cream Tsiklovir according to the instructions is used for infections of the skin, caused by the virus Herpes simplex and Varicella zoster.
Tsiklovir for instructions apply contraindicated in case of hypersensitivity to the active ingredient (acyclovir) or auxiliaries, which is part of the medication.
The ability to use Tsiklovira pregnancy is determined individually based on the physician alleged benefit or harm from the drug to the mother and child.
Application Tsiklovira during breastfeeding is not recommended to avoid the release of the active drug ingredient in breast milk.
Tsiklovir as an ointment or cream for external use is not used for application to the mucous membranes of the eyes, mouth, and vagina.
Tsiklovir Inside are adults and children from two years to a single dose of 1-2 tablets with a multiplicity of applications from three to five times a day.
Younger children dosage Tsiklovira usually halved.
The duration of treatment medication - from five to ten days, but in patients with renal insufficiency dosing regimen should be adjusted.
Side effects Tsiklovira
Most often Tsiklovir Review ingestion causes:
• abdominal pain;
• skin rash;
• Reduced concentration;
• drowsiness or insomnia.
Much less when taking Tsiklovira Review may develop:
increasing the concentration of bilirubin in the blood;
• hair loss;
At the local and external use Tsiklovir Review can cause:
• A burning sensation that occurs at the site of application;
• Superficial punctate keratitis;
• skin rash;
• Dry skin.
In case of contact with mucous membranes Tsiklovira may begin inflammation.
Drug interaction Tsiklovira
The risk of nephrotoxicity increases dramatically while the application Tsiklovira with nephrotoxic drugs, especially against the background of violations of kidney function.
Enhancing Tsiklovira observed with concomitant administration with immunostimulants.
Tsiklovir in pill form can be stored no more than three years, in the form of ointments and creams outdoor - up to two years (subject to compliance with the recommended storage conditions).